Measuring Family Engagement in Care (The FAME Study)

Sponsor
Lady Davis Institute (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05659485
Collaborator
Jewish General Hospital (Other)
198
4
14.9
49.5
3.3

Study Details

Study Description

Brief Summary

There are currently no validated tools to specifically measure family engagement in the intensive care unit (ICU). To address this gap, an interdisciplinary team developed a novel instrument to measure family engagement in the ICU. This will be a prospective observational cohort with an embedded qualitative study to validate the FAMily Engagement (FAME) instrument in the ICU setting. This study will also evaluate the association between family activation, engagement, and family-centred outcomes, and exploring factors (age, relationship, sex, gender, race/ethnicity) that may influence family engagement in the ICU.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This will be a prospective observational cohort study of 198 family members in the ICUs of 4 Canadian hospitals in 3 provinces (Alberta, Ontario, and Quebec) over a 12-week period. These sites were chosen due to their urban setting and distant geographic range to capture differing practice patterns, a higher percentage of racialized patients, and language and cultural differences. The target recruitment is 50 family members from each participating site. A "family member" will be considered anyone with a biological, legal, or emotional relationship with the patient and whom the patient would want involved in their care.

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    198 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Measuring Family Engagement in Care (The FAME Study)
    Anticipated Study Start Date :
    Jan 2, 2023
    Anticipated Primary Completion Date :
    Mar 30, 2024
    Anticipated Study Completion Date :
    Mar 30, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Family engagement in care (as measured by FAME) [Within 24 hours of enrolment]

      The FAMily Engagement (FAME) questionnaire is an instrument developed to assess current family engagement practice. Items address key principles of family-centered care, such as dignity and respect, information sharing, participation, and collaboration. They also address family engagement domains, including family presence, family needs, communication and education, decision making, and direct care. A five-point Likert scale (1=strongly agree, 2=agree, 3=neutral, 4=disagree, 5=strongly disagree) is used for responses, which are then transformed to a 0-100 scoring system, with higher scores indicating greater engagement in care and lower scores indicating lesser engagement in care. The overall engagement score is calculated by dividing the sum of the scores by the number of questions answered, with the result ranging from 0-100.

    Secondary Outcome Measures

    1. Family activation (as measured by FAM-Activate) [Within 24 hours of enrolment]

      FAM-Activate is a 4-question measure that assesses the family member's knowledge, skills, and confidence concerning care participation.

    2. Family mental health (as measured by HADS) [Within 2 weeks of hospital discharge.]

      The Hospital Anxiety and Depression Scale (HADS) survey is a validated self-reported instrument to measure anxiety and depression in medical patients. The survey consists of 14 questions (7 depression-related and 7 anxiety-related) which are scored on a 4-point Likert scale (0-3). The sum of the sub-scores on each of the two subscales (anxiety and depression) represents the total score. A lower total score indicates a milder condition whereas a higher total score indicates a higher level of distress.

    3. Family care satisfaction (as measured by FS-ICU 24) [Within 2 weeks of hospital discharge.]

      The Family Satisfaction in the ICU survey (FS-ICU 24) is a validated 24-item self-report instrument that assesses family satisfaction and experience with care in the ICU.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Family member of patient admitted to the intensive care units

    • Able to participate in English or French

    • Age 18 years old or older

    Exclusion Criteria:
    • ICU stays less than 24 hours

    • Another family member has already participated in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Foothills Medical Centre Calgary Alberta Canada
    2 St. Michael's Hospital Toronto Ontario Canada
    3 Royal Victoria Hospital Montreal Quebec Canada
    4 Jewish General Hospital / Lady Davis Institute Montréal Quebec Canada H3T 1E2

    Sponsors and Collaborators

    • Lady Davis Institute
    • Jewish General Hospital

    Investigators

    • Principal Investigator: Michael J Goldfarb, MD MSc, Lady Davis Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Michael Goldfarb, Attending Staff, Division of Cardiology, Lady Davis Institute
    ClinicalTrials.gov Identifier:
    NCT05659485
    Other Study ID Numbers:
    • 2022-3191
    First Posted:
    Dec 21, 2022
    Last Update Posted:
    Dec 21, 2022
    Last Verified:
    Dec 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Michael Goldfarb, Attending Staff, Division of Cardiology, Lady Davis Institute

    Study Results

    No Results Posted as of Dec 21, 2022